Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    TARDBP
Show Display Options
Rank Status Study
1 Unknown  Tamoxifen Treatment in Patients With Motor Neuron Disease
Conditions: Amyotrophic Lateral Sclerosis;   ALS Functional Ration Scale;   TAR-DNA-binding Protein-43;   Tamoxifen;   mTOR
Intervention: Drug: tamoxifen 40 mg daily for one year

Indicates status has not been verified in more than two years